Who owns the TRANSFORMING RADIOTHERAPY trademark?

The TRANSFORMING RADIOTHERAPY trademark is owned by Galera Therapeutics, Inc..

What class is the TRANSFORMING RADIOTHERAPY trademark registered in?

The TRANSFORMING RADIOTHERAPY trademark is registered in Class 042 (Scientific, technology & SaaS services).

What is the serial number for TRANSFORMING RADIOTHERAPY?

The USPTO serial number for TRANSFORMING RADIOTHERAPY is 90976164.

What is the registration number for TRANSFORMING RADIOTHERAPY?

TRANSFORMING RADIOTHERAPY is registered under USPTO registration number 6708709.

TRA

USPTO Trademark Record

REGISTERED

TRANSFORMING RADIOTHERAPY

SN 90976164·Reg 6708709·Filed Oct 08, 2020

Owner Galera Therapeutics, Inc.

Scientific and technological services and research and design relating thereto; industrial analysis, industrial research and industrial design services; quality control and authentication services; design and development of computer hardware and software.

TRANSFORMING RADIOTHERAPY (Serial No. 90976164), Registration No. 6708709, is a registered US trademark filed on Oct 08, 2020 by Galera Therapeutics, Inc.. This trademark covers Class 042 (Scientific, technology & SaaS services).

early section 8: April 19, 2028

Mark Intelligence

TRANSFORMING RADIOTHERAPY (Reg. #6708709) is a registered US trademark that has been protecting its owner, Galera Therapeutics, Inc., since 2020. The mark covers Class 042 (Scientific, technology & SaaS services). Goods and services include Scientific and technological services and research and design relating thereto; industrial analysis, industrial research.... The mark faced 1 opposition proceeding during prosecution.

FILED

Oct 08, 2020

SERIAL

90976164

REG#

6708709

REGISTERED

Apr 19, 2022

Owner

Applicant

Galera Therapeutics, Inc.

Entity

Corporation

State

Address

2 West Liberty Boulevard, Suite 100, Malvern, PA, 19355

Country

Attorney

NameMonica Riva Talley

Law firm

Monica Riva Talley STERNE, KESSLER, GOLDSTEIN & FOX P.L.L.C.

Docket

4025.0080000

Address

1100 NEW YORK AVENUE, NW, WASHINGTON, DC 20005, UNITED STATES

Get pre-filing clearance

AI attorney analyzes your proposed mark against USPTO — Go/No-Go verdict, class-by-class risks, and strategy recommendations.

Run clearance

Filing Information

StatusREGISTERED

Filing DateOct 08, 2020

Serial Number90976164

Registration No.6708709

Registration DateApr 19, 2022

Status DateApr 19, 2022

Published for OppositionApr 13, 2021

Mark TypeStandard characters

Attorney Docket4025.0080000

Status DescriptionLive and registered

Filing Signals

FILED

2020

YEARS AGO

CLASSES

MADRID FILINGS

—

Opposed 1× during prosecution

Search 14M+ trademarks

Free USPTO lookups by name, owner, or serial number. No account needed.

Search now

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 042Scientific, technology & SaaS services

US codes: 100, 101

First use anywhere: Dec 31, 2018

First use in commerce: Dec 31, 2018

This description is as filed with the USPTO and defines the scope of trademark protection.

Status History

29 events

REGISTERED-PRINCIPAL REGISTER

Apr 19, 2022

REGISTERED-PRINCIPAL REGISTER

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

Mar 16, 2022

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

Mar 15, 2022

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

ASSIGNED TO LIE

Mar 14, 2022

ASSIGNED TO LIE

CORRESPONDENCE RECEIVED IN LAW OFFICE

Mar 14, 2022

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS/EMAIL CORRESPONDENCE ENTERED

Mar 14, 2022

TEAS/EMAIL CORRESPONDENCE ENTERED

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Mar 10, 2022

TEAS RESPONSE TO OFFICE ACTION RECEIVED

SU - NON-FINAL ACTION - WRITTEN

Jan 07, 2022

SU - NON-FINAL ACTION - WRITTEN

NON-FINAL ACTION E-MAILED

Jan 07, 2022

NON-FINAL ACTION E-MAILED

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Jan 07, 2022

NOTIFICATION OF NON-FINAL ACTION E-MAILED

DIVISIONAL PROCESSING COMPLETE

Dec 20, 2021

DIVISIONAL PROCESSING COMPLETE

STATEMENT OF USE PROCESSING COMPLETE

Dec 20, 2021

STATEMENT OF USE PROCESSING COMPLETE

CASE ASSIGNED TO INTENT TO USE PARALEGAL

Dec 17, 2021

CASE ASSIGNED TO INTENT TO USE PARALEGAL

TEAS STATEMENT OF USE RECEIVED

Dec 07, 2021

TEAS STATEMENT OF USE RECEIVED

TEAS REQUEST TO DIVIDE RECEIVED

Dec 07, 2021

TEAS REQUEST TO DIVIDE RECEIVED

USE AMENDMENT FILED

Dec 07, 2021

USE AMENDMENT FILED

DIVISIONAL REQUEST RECEIVED

Dec 07, 2021

DIVISIONAL REQUEST RECEIVED

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Jun 08, 2021

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

PUBLISHED FOR OPPOSITION

Apr 13, 2021

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Apr 13, 2021

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Mar 24, 2021

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

EXAMINERS AMENDMENT -WRITTEN

Mar 09, 2021

EXAMINERS AMENDMENT -WRITTEN

EXAMINERS AMENDMENT E-MAILED

Mar 09, 2021

EXAMINERS AMENDMENT E-MAILED

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

Mar 09, 2021

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

EXAMINER'S AMENDMENT ENTERED

Mar 09, 2021

EXAMINER'S AMENDMENT ENTERED

APPROVED FOR PUB - PRINCIPAL REGISTER

Mar 09, 2021

APPROVED FOR PUB - PRINCIPAL REGISTER

ASSIGNED TO EXAMINER

Mar 08, 2021

ASSIGNED TO EXAMINER

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Nov 23, 2020

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

NEW APPLICATION ENTERED

Oct 12, 2020

NEW APPLICATION ENTERED

TRANSFORMING RADIOTHERAPY

Get pre-filing clearance

Search 14M+ trademarks

Run a conflict check

Other Marks by Galera Therapeutics, Inc.

Other Marks in Class 042 — Scientific, technology & SaaS services

Other Marks by Monica Riva Talley

Resources

Company